Find a Research Study

Find a Research Study

Find a Research Study

Find a Research Study

Find a Research Study

Safety and Immunogenicity of pneumococcal vaccine VAX-31 in Healthy Infants

To evaluate the safety and tolerability of VAX-31 at 3 dose levels administered to healthy infants at 2, 4, 6, and 12-15 months of age alone and compared to PCV20.


Why this Research Matters

This study is testing a new 31 valent pneumococcal vaccine against the current 20 valent pneumococcal vaccine. The study includes 5 visits, vaccine injections and 3 blood draws. Parents will fill out an e-diary after vaccination.


Who can Participate

Healthy full term infants between 42 and 89 days old


Study ID

Protocol Number: 25-0133


Meet the Team

Image of Principal Investigator

Eric Simoes, MD

Principal Investigator